Dr. Stuart Titus, Ph.D., is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. by becoming its seventh investor. Titus’ is also a Wall Street veteran, where he was a bond trader for 11 years. Dr. Titus earned his undergraduate degree at Rollins College, and his Ph.D. from the Open International University. Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.
The FDA has mistakenly substituted the adverse effects of Epidiolex, a refined, isolated and semi-synthetic form of CBD, as being the same form of CBD that is being sold by those in the nutritional supplement industry.
The FDA issued 15 warning letters to cannabis companies and released a revised Consumer Update detailing its new safety concerns about CBD products, in particular the safety of CBD in food.